Wei W, Zeng H, Zheng R, Zhang S, An L, Chen R, Wang S, Solar Okay, Matsuda T, Bray F, et al. Most cancers registration in China and its position in most cancers prevention and management. Lancet Oncol. 2020;21(7):e342–9.
Housman G, Byler S, Heerboth S, Lapinska Okay, Longacre M, Snyder N, Sarkar S. Drug resistance in most cancers: an summary. Cancers. 2014;6(3):1769–92.
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an rising platform for most cancers remedy. Nat Nanotechnol. 2007;2(12):751–60.
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, et al. Nano primarily based drug supply methods: latest developments and future prospects. J Nanobiotechnol. 2018;16(1):71.
Wilhelm S, Tavares AJ, Dai Q, Ohta S, Audet J, Dvorak HF, Chan WCW. Evaluation of nanoparticle supply to tumours. Nat Rev Mater. 2016;1(5):16014.
Yong T, Wang D, Li X, Yan Y, Hu J, Gan L, Yang X. Extracellular vesicles for tumor concentrating on supply primarily based on 5 options precept. J Management Launch. 2020;322:555–65.
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, et al. Minimal data for research of extracellular vesicles 2018 (MISEV2018): a place assertion of the Worldwide Society for Extracellular Vesicles and replace of the MISEV2014 pointers. J Extracell Vesicles. 2018;7(1):1535750.
Montecalvo A, Shufesky WJ, Stolz DB, Sullivan MG, Wang Z, Divito SJ, Papworth GD, Watkins SC, Robbins PD, Larregina AT, et al. Exosomes as a short-range mechanism to unfold alloantigen between dendritic cells throughout T cell allorecognition. J Immunol. 2008;180(5):3081–90.
Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO. Glioblastoma microvesicles transport RNA and proteins that promote tumour progress and supply diagnostic biomarkers. Nat Cell Biol. 2008;10(12):1470–6.
Sarkar A, Mitra S, Mehta S, Raices R, Wewers MD. Monocyte derived microvesicles ship a cell demise message through encapsulated caspase-1. PLoS ONE. 2009;4(9):e7140.
Track S, Zhu L, Wang C, Yang Y. In vitro diagnostic applied sciences for the detection of extracellular vesicles: present standing and future instructions. VIEW. 2023;4(2):20220011.
Valadi H, Ekström Okay, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated switch of mRNAs and microRNAs is a novel mechanism of genetic alternate between cells. Nat Cell Biol. 2007;9(6):654–9.
Lewis JM, Vyas AD, Qiu Y, Messer KS, White R, Heller MJ. Built-in evaluation of exosomal protein biomarkers on alternating present electrokinetic chips permits speedy detection of pancreatic most cancers in affected person blood. ACS Nano. 2018;12(4):3311–20.
Cavallaro S, Horak J, Hååg P, Gupta D, Stiller C, Sahu SS, Görgens A, Gatty HK, Viktorsson Okay, El Andaloussi S, et al. Label-free floor protein profiling of extracellular vesicles by an electrokinetic sensor. ACS Sens. 2019;4(5):1399–408.
Yan Z, Dutta S, Liu Z, Yu X, Mesgarzadeh N, Ji F, Bitan G, Xie YH. A label-free platform for identification of exosomes from totally different sources. ACS Sens. 2019;4(2):488–97.
Zhang L, He F, Gao L, Cong M, Solar J, Xu J, Wang Y, Hu Y, Asghar S, Hu L, et al. engineering exosome-like nanovesicles derived from asparagus cochinchinensis can inhibit the proliferation of hepatocellular carcinoma cells with higher security profile. Int J Nanomed. 2021;16:1575–86.
Kandimalla R, Aqil F, Alhakeem SS, Jeyabalan J, Tyagi N, Agrawal A, Yan J, Spencer W, Bondada S, Gupta RC. Focused oral supply of paclitaxel utilizing colostrum-derived exosomes. Cancers. 2021;13(15):3700.
Tan S, Wu T, Zhang D, Zhang Z. Cell or cell membrane-based drug supply methods. Theranostics. 2015;5(8):863–81.
Guo P, Busatto S, Huang J, Morad G, Moses MA. A facile magnetic extrusion technique for getting ready endosome-derived vesicles for most cancers drug supply. Adv Funct Mater. 2021;31(44):2008326.
Wan Y, Wang L, Zhu C, Zheng Q, Wang G, Tong J, Fang Y, Xia Y, Cheng G, He X, et al. Aptamer-conjugated extracellular nanovesicles for focused drug supply. Most cancers Res. 2018;78(3):798–808.
Gong YK, Winnik FM. Methods in biomimetic floor engineering of nanoparticles for biomedical purposes. Nanoscale. 2012;4(2):360–8.
Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S. Microfluidic machine (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip. 2014;14(11):1891–900.
Tian T, Zhu YL, Zhou YY, Liang GF, Wang YY, Hu FH, Xiao ZD. Exosome uptake by clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 supply. J Biol Chem. 2014;289(32):22258–67.
Xu B, Zhang Y, Du XF, Li J, Zi HX, Bu JW, Yan Y, Han H, Du JL. Neurons secrete miR-132-containing exosomes to manage mind vascular integrity. Cell Res. 2017;27(7):882–97.
Cheng Q, Shi X, Han M, Smbatyan G, Lenz HJ, Zhang Y. Reprogramming exosomes as nanoscale controllers of mobile immunity. J Am Chem Soc. 2018;140(48):16413–7.
Liu H, Huang L, Mao M, Ding J, Wu G, Fan W, Yang T, Zhang M, Huang Y, Xie H-Y. Viral protein-pseudotyped and siRNA-electroporated extracellular vesicles for most cancers immunotherapy. Adv Func Mater. 2020;30(52):2006515.
Cheng L, Zhang X, Tang J, Lv Q, Liu J. Gene-engineered exosomes-thermosensitive liposomes hybrid nanovesicles by the blockade of CD47 sign for mixed photothermal remedy and most cancers immunotherapy. Biomaterials. 2021;275:120964.
Qing S, Lyu C, Zhu L, Pan C, Wang S, Li F, Wang J, Yue H, Gao X, Jia R, et al. Biomineralized bacterial outer membrane vesicles potentiate protected and environment friendly tumor microenvironment reprogramming for anticancer remedy. Adv Mater. 2020;32(47):2002085.
Liu W, Li L, Jiang J, Wu M, Lin P. Purposes and challenges of CRISPR-Cas gene-editing to illness therapy in clinics. Summary Clin Med. 2021;4(3):179–91.
Xu Q, Zhang Z, Zhao L, Qin Y, Cai H, Geng Z, Zhu X, Zhang W, Zhang Y, Tan J, et al. Tropism-facilitated supply of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles towards B-cell malignancies. J Management Launch. 2020;326:455–67.
Wang Y, Cao Z, Wei Q, Ma Okay, Hu W, Huang Q, Su J, Li H, Zhang C, Fu X. VH298-loaded extracellular vesicles launched from gelatin methacryloyl hydrogel facilitate diabetic wound therapeutic by HIF-1α-mediated enhancement of angiogenesis. Acta Biomater. 2022;147:342–55.
Track X, Xu L, Zhang W. Biomimetic synthesis and optimization of extracellular vesicles for bone regeneration. J Management Launch. 2023;355:18–41.
Xu M, Feng T, Liu B, Qiu F, Xu Y, Zhao Y, Zheng Y. Engineered exosomes: fascinating target-tracking traits for cerebrovascular and neurodegenerative illness therapies. Theranostics. 2021;11(18):8926–44.
Du J, Wan Z, Wang C, Lu F, Wei M, Wang D, Hao Q. Designer exosomes for focused and environment friendly ferroptosis induction in most cancers through chemo-photodynamic remedy. Theranostics. 2021;11(17):8185–96.
Lv Q, Cheng L, Lu Y, Zhang X, Wang Y, Deng J, Zhou J, Liu B, Liu J. Thermosensitive exosome-liposome hybrid nanoparticle-mediated chemoimmunotherapy for improved therapy of metastatic peritoneal most cancers. Adv Sci. 2020;7(18):2000515.
Bose RJ, Kumar US, Garcia-Marques F, Zeng Y, Habte F, McCarthy JR, Pitteri S, Massoud TF, Paulmurugan R. Engineered cell-derived vesicles displaying concentrating on peptide and functionalized with nanocarriers for therapeutic microrna supply to triple-negative breast most cancers in mice. Adv Healthc Mater. 2022;11(5):e2101387.
Mahati S, Fu X, Ma X, Zhang H, Xiao L. Supply of miR-26a utilizing an exosomes-based nanosystem inhibited proliferation of hepatocellular carcinoma. Entrance Mol Biosci. 2021;8:738219.
Shi X, Cheng Q, Hou T, Han M, Smbatyan G, Lang JE, Epstein AL, Lenz HJ, Zhang Y. Genetically engineered cell-derived nanoparticles for focused breast most cancers immunotherapy. Mol Ther. 2020;28(2):536–47.
Wang L, Zhou X, Zou W, Wu Y, Zhao J, Chen X, Zhou GG. Exosomes containing miRNAs concentrating on HER2 synthesis and engineered to stick to HER2 on tumor cells floor exhibit enhanced antitumor exercise. J Nanobiotechnology. 2020;18(1):153.
Wang JH, Forterre AV, Zhao J, Frimannsson DO, Delcayre A, Antes TJ, Efron B, Jeffrey SS, Pegram MD, Matin AC. Anti-HER2 scFv-directed extracellular vesicle-mediated mRNA-based gene supply inhibits progress of HER2-positive human breast tumor xenografts by prodrug activation. Mol Most cancers Ther. 2018;17(5):1133–42.
Zhang P, Zhang L, Qin Z, Hua S, Guo Z, Chu C, Lin H, Zhang Y, Li W, Zhang X, et al. Genetically engineered liposome-like nanovesicles as lively focused transport platform. Adv Mater. 2018;30(7):1705350.
Gomari H, Forouzandeh Moghadam M, Soleimani M, Ghavami M, Khodashenas S. Focused supply of doxorubicin to HER2 optimistic tumor fashions. Int J Nanomed. 2019;14:5679–90.
Liang G, Zhu Y, Ali DJ, Tian T, Xu H, Si Okay, Solar B, Chen B, Xiao Z. Engineered exosomes for focused co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon most cancers. J Nanobiotechnology. 2020;18(1):10.
Ma G, Severic M, Barker M, Pereira S, Ruiz A, Cheung CCL, Al-Jamal WT. Dually focused bioinspired nanovesicle delays superior prostate most cancers tumour progress in vivo. Acta Biomater. 2021;134:559–75.
Wang Okay, Kumar US, Sadeghipour N, Massoud TF, Paulmurugan R. A microfluidics-based scalable method to generate extracellular vesicles with enhanced therapeutic microRNA loading for intranasal supply to mouse glioblastomas. ACS Nano. 2021;15(11):18327–46.
Xu S, Liu B, Fan J, Xue C, Lu Y, Li C, Cui D. Engineered mesenchymal stem cell-derived exosomes with excessive CXCR4 ranges for focused siRNA gene remedy towards most cancers. Nanoscale. 2022;14(11):4098–113.
Kim G, Kim M, Lee Y, Byun JW, Hwang DW, Lee M. Systemic supply of microRNA-21 antisense oligonucleotides to the mind utilizing T7-peptide adorned exosomes. J Management Launch. 2020;317:273–81.
Han S, Li G, Jia M, Zhao Y, He C, Huang M, Jiang L, Wu M, Yang J, Ji X, et al. Supply of anti-miRNA-221 for colorectal carcinoma remedy utilizing modified wire blood mesenchymal stem cells-derived exosomes. Entrance Mol Biosci. 2021;8:743013.
Shi Y, Lin G, Zheng H, Mu D, Chen H, Lu Z, He P, Zhang Y, Liu C, Lin Z, et al. Biomimetic nanoparticles blocking autophagy for enhanced chemotherapy and metastasis inhibition through reversing focal adhesion disassembly. J Nanobiotechnology. 2021;19(1):447.
Jiang L, Gu Y, Du Y, Tang X, Wu X, Liu J. Engineering exosomes endowed with focused supply of triptolide for malignant melanoma remedy. ACS Appl Mater Interfaces. 2021;13(36):42411–28.
Zhuang M, Chen X, Du D, Shi J, Deng M, Lengthy Q, Yin X, Wang Y, Rao L. SPION adorned exosome supply of TNF-α to most cancers cell membranes by magnetism. Nanoscale. 2020;12(1):173–88.
Chen Y, Wang L, Zheng M, Zhu C, Wang G, Xia Y, Blumenthal EJ, Mao W, Wan Y. Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy. Bioact Mater. 2022;9:251–65.
Liu C, Liu X, Xiang X, Pang X, Chen S, Zhang Y, Ren E, Zhang L, Liu X, Lv P, et al. A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalised most cancers immunotherapy technique. Nat Nanotechnol. 2022;17(5):531–40.
Wang S, Huang W, Li Okay, Yao Y, Yang X, Bai H, Solar W, Liu C, Ma Y. Engineered outer membrane vesicle is potent to elicit HPV16E7-specific mobile immunity in a mouse mannequin of TC-1 graft tumor. Int J Nanomed. 2017;12:6813–25.
Huang W, Shu C, Hua L, Zhao Y, Xie H, Qi J, Gao F, Gao R, Chen Y, Zhang Q, et al. Modified bacterial outer membrane vesicles induce autoantibodies for tumor remedy. Acta Biomater. 2020;108:300–12.
Huang L, Rong Y, Tang X, Yi Okay, Qi P, Hou J, Liu W, He Y, Gao X, Yuan C, et al. Engineered exosomes as an in situ DC-primed vaccine to spice up antitumor immunity in breast most cancers. Mol Most cancers. 2022;21(1):45.
Feng C, Xiong Z, Wang C, Xiao W, Xiao H, Xie Okay, Chen Okay, Liang H, Zhang X, Yang H. Folic acid-modified exosome-PH20 enhances the effectivity of remedy through modulation of the tumor microenvironment and instantly inhibits tumor cell metastasis. Bioact Mater. 2021;6(4):963–74.
Kamerkar S, Leng C, Burenkova O, Jang SC, McCoy C, Zhang Okay, Dooley Okay, Kasera S, Zi T, Sisó S, et al. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 results in potent monotherapy antitumor exercise. Sci Adv. 2022;8(7):eabj7002.
Zhou W, Xu M, Wang Z, Yang M. Engineered exosomes loaded with miR-449a selectively inhibit the expansion of homologous non-small cell lung most cancers. Most cancers Cell Int. 2021;21(1):485.
Blanco E, Shen H, Ferrari M. Rules of nanoparticle design for overcoming organic obstacles to drug supply. Nat Biotechnol. 2015;33(9):941–51.
El-Boubbou Okay. Magnetic iron oxide nanoparticles as drug carriers: scientific relevance. Nanomedicine. 2018;13(8):953–71.
Wang J, Potocny AM, Rosenthal J, Day ES. Gold nanoshell-linear tetrapyrrole conjugates for close to infrared-activated twin photodynamic and photothermal therapies. ACS Omega. 2020;5(1):926–40.
Bayda S, Hadla M, Palazzolo S, Riello P, Corona G, Toffoli G, Rizzolio F. Inorganic nanoparticles for most cancers remedy: a transition from lab to clinic. Curr Med Chem. 2018;25(34):4269–303.
Liu Y, Luo J, Chen X, Liu W, Chen T. Cell membrane coating expertise: a promising technique for biomedical purposes. Nanomicro Lett. 2019;11(1):100.
Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug supply. Nat Rev Drug Discov. 2021;20(2):101–24.
Sedighi M, Sieber S, Rahimi F, Shahbazi MA, Rezayan AH, Huwyler J, Witzigmann D. Speedy optimization of liposome traits utilizing a mixed microfluidics and design-of-experiment method. Drug Deliv Transl Res. 2019;9(1):404–13.
Xiong F, Ling X, Chen X, Chen J, Tan J, Cao W, Ge L, Ma M, Wu J. Pursuing particular chemotherapy of orthotopic breast most cancers with lung metastasis from docking nanoparticles pushed by bioinspired exosomes. Nano Lett. 2019;19(5):3256–66.
Zhao L, Gu C, Gan Y, Shao L, Chen H, Zhu H. Exosome-mediated siRNA supply to suppress postoperative breast most cancers metastasis. J Management Launch. 2020;318:1–15.
Li M, Li S, Zhou H, Tang X, Wu Y, Jiang W, Tian Z, Zhou X, Yang X, Wang Y. Chemotaxis-driven supply of nano-pathogenoids for full eradication of tumors post-phototherapy. Nat Commun. 2020;11(1):1126.
Zhang D, Qin X, Wu T, Qiao Q, Track Q, Zhang Z. Extracellular vesicles primarily based self-grown gold nanopopcorn for combinatorial chemo-photothermal remedy. Biomaterials. 2019;197:220–8.
Bose RJC, Uday Kumar S, Zeng Y, Afjei R, Robinson E, Lau Okay, Bermudez A, Habte F, Pitteri SJ, Sinclair R, et al. Tumor cell-derived extracellular vesicle-coated nanocarriers: an environment friendly theranostic platform for the cancer-specific supply of anti-miR-21 and imaging brokers. ACS Nano. 2018;12(11):10817–32.
Shen WT, Hsu RS, Fang JH, Hu PF, Chiang CS, Hu SH. Marginative delivery-mediated extracellular leakiness and T cell infiltration in lung metastasis by a biomimetic nanoraspberry. Nano Lett. 2021;21(3):1375–83.
Jia G, Han Y, An Y, Ding Y, He C, Wang X, Tang Q. NRP-1 focused and cargo-loaded exosomes facilitate simultaneous imaging and remedy of glioma in vitro and in vivo. Biomaterials. 2018;178:302–16.
Wang G, Hu W, Chen H, Shou X, Ye T, Xu Y. Cocktail technique primarily based on NK cell-derived exosomes and their biomimetic nanoparticles for twin tumor remedy. Cancers. 2019;11(10):1560.
Chen Q, Bai H, Wu W, Huang G, Li Y, Wu M, Tang G, Ping Y. Bioengineering bacterial vesicle-coated polymeric nanomedicine for enhanced most cancers immunotherapy and metastasis prevention. Nano Lett. 2020;20(1):11–21.
Zhupanyn P, Ewe A, Büch T, Malek A, Rademacher P, Müller C, Reinert A, Jaimes Y, Aigner A. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA supply in vitro and in vivo. J Management Launch. 2020;319:63–76.
Li S, Wu Y, Ding F, Yang J, Li J, Gao X, Zhang C, Feng J. Engineering macrophage-derived exosomes for focused chemotherapy of triple-negative breast most cancers. Nanoscale. 2020;12(19):10854–62.
Wang D, Yao Y, He J, Zhong X, Li B, Rao S, Yu H, He S, Feng X, Xu T, et al. Engineered cell-derived microparticles Bi(2)Se(3)/DOX@MPs for imaging guided synergistic photothermal/low-dose chemotherapy of most cancers. Adv Sci. 2020;7(3):1901293.
Sancho-Albero M, Encinas-Giménez M, Sebastián V, Pérez E, Luján L, Santamaría J, Martin-Duque P. Switch of photothermal nanoparticles utilizing stem cell derived small extracellular vesicles for in vivo therapy of main and multinodular tumours. J Extracell Vesicles. 2022;11(3):e12193.
Cao Y, Wu T, Zhang Okay, Meng X, Dai W, Wang D, Dong H, Zhang X. Engineered exosome-mediated near-infrared-II area V(2)C quantum dot supply for nucleus-target low-temperature photothermal remedy. ACS Nano. 2019;13(2):1499–510.
Cheng G, Li W, Ha L, Han X, Hao S, Wan Y, Wang Z, Dong F, Zou X, Mao Y, et al. Self-assembly of extracellular vesicle-like metal-organic framework nanoparticles for defense and intracellular supply of biofunctional proteins. J Am Chem Soc. 2018;140(23):7282–91.
Tian R, Wang Z, Niu R, Wang H, Guan W, Chang J. tumor exosome mimicking nanoparticles for tumor combinatorial chemo-photothermal remedy. Entrance Bioeng Biotechnol. 2020;8:1010.
Nie D, Dai Z, Li J, Yang Y, Xi Z, Wang J, Zhang W, Qian Okay, Guo S, Zhu C, et al. Most cancers-cell-membrane-coated nanoparticles with a yolk-shell construction increase most cancers chemotherapy. Nano Lett. 2020;20(2):936–46.
Wu T, Liu Y, Cao Y, Liu Z. Engineering macrophage exosome disguised biodegradable nanoplatform for enhanced sonodynamic remedy of glioblastoma. Adv Mater. 2022;34(15):e2110364.
Cao X, Tan T, Zhu D, Yu H, Liu Y, Zhou H, Jin Y, Xia Q. Paclitaxel-loaded macrophage membrane camouflaged albumin nanoparticles for focused most cancers remedy. Int J Nanomedicine. 2020;15:1915–28.
Jiang Q, Liu Y, Guo R, Yao X, Sung S, Pang Z, Yang W. Erythrocyte-cancer hybrid membrane-camouflaged melanin nanoparticles for enhancing photothermal remedy efficacy in tumors. Biomaterials. 2019;192:292–308.
Ma Y, Zhang Y, Han R, Li Y, Zhai Y, Qian Z, Gu Y, Li S. A cascade synergetic technique induced by photothermal impact primarily based on platelet exosome nanoparticles for tumor remedy. Biomaterials. 2022;282:121384.
Zhou X, Miao Y, Wang Y, He S, Guo L, Mao J, Chen M, Yang Y, Zhang X, Gan Y. Tumour-derived extracellular vesicle membrane hybrid lipid nanovesicles improve siRNA supply by tumour-homing and intracellular freeway transportation. J Extracell Vesicles. 2022;11(3):e12198.
Deng L, Zhang H, Zhang Y, Luo S, Du Z, Lin Q, Zhang Z, Zhang L. An exosome-mimicking membrane hybrid nanoplatform for focused therapy towards Kras-mutant pancreatic carcinoma. Biomater Sci. 2021;9(16):5599–611.
Tan YN, Huang JD, Li YP, Li SS, Luo M, Luo J, Lee AW, Fu L, Hu FQ, Guan XY. Close to-infrared responsive membrane nanovesicles amplify homologous concentrating on supply of anti-PD immunotherapy towards metastatic tumors. Adv Healthc Mater. 2022;11(6):e2101496.
Tian T, Liang R, Erel-Akbaba G, Saad L, Obeid PJ, Gao J, Chiocca EA, Weissleder R, Tannous BA. Immune checkpoint inhibition in GBM primed with radiation by engineered extracellular vesicles. ACS Nano. 2022;16(2):1940–53.
Guo L, Guo Y, Lau DHM, Xu YC. A novel particular small molecule peptide for non-small cell lung most cancers cell A549. Progress Biochem Biophys. 2007;34:1080–5.
Lin Q, Qu M, Zhou B, Patra HK, Solar Z, Luo Q, Yang W, Wu Y, Zhang Y, Li L, et al. Exosome-like nanoplatform modified with concentrating on ligand improves anti-cancer and anti-inflammation results of imperialine. J Management Launch. 2019;311–312:104–16.
Nie W, Wu G, Zhang J, Huang LL, Ding J, Jiang A, Zhang Y, Liu Y, Li J, Pu Okay, et al. Responsive exosome nano-bioconjugates for synergistic most cancers remedy. Angew Chem Int Ed Engl. 2020;59(5):2018–22.
Wu H, Zhu L, Torchilin VP. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug supply. Biomaterials. 2013;34(4):1213–22.
de Guimarães MS, Cachumba JJM, Bueno CZ, Torres-Obreque KM, Lara GVR, Monteiro G, Barbosa LRS, Pessoa A Jr, Rangel-Yagui CO. Peg-grafted liposomes for l-asparaginase encapsulation. Pharmaceutics. 2022;14(9):1819.
Zhuang J, Tan J, Wu C, Zhang J, Liu T, Fan C, Li J, Zhang Y. Extracellular vesicles engineered with valency-controlled DNA nanostructures ship CRISPR/Cas9 system for gene remedy. Nucleic Acids Res. 2020;48(16):8870–82.
Zhan Q, Yi Okay, Cui X, Li X, Yang S, Wang Q, Fang C, Tan Y, Li L, Xu C, et al. Blood exosomes-based focused supply of cPLA2 siRNA and metformin to modulate glioblastoma power metabolism for tailoring customized remedy. Neuro Oncol. 2022;24(11):1871–83.
Peng B, Nguyen TM, Jayasinghe MK, Gao C, Pham TT, Vu LT, Yeo EYM, Yap G, Wang L, Goh BC, et al. Sturdy supply of RIG-I agonists utilizing extracellular vesicles for anti-cancer immunotherapy. J Extracell Vesicles. 2022;11(4):e12187.
Pham TC, Jayasinghe MK, Pham TT, Yang Y, Wei L, Usman WM, Chen H, Pirisinu M, Gong J, Kim S, et al. Covalent conjugation of extracellular vesicles with peptides and nanobodies for focused therapeutic supply. J Extracell Vesicles. 2021;10(4):e12057.
Li R, Gong X, Hong C, Wang H, Chen Y, Tan Okay, Liu X, Wang F. An environment friendly photochemotherapy nanoplatform primarily based on the endogenous biosynthesis of photosensitizer in macrophage-derived extracellular vesicles. Biomaterials. 2021;279:121234.
Zheng Z, Li Z, Xu C, Guo B, Guo P. Folate-displaying exosome mediated cytosolic supply of siRNA avoiding endosome trapping. J Management Launch. 2019;311–312:43–9.
Kwon SH, Faruque HA, Kee H, Kim E, Park S. Exosome-based hybrid nanostructures for enhanced tumor concentrating on and hyperthermia remedy. Colloids Surf B Biointerfaces. 2021;205:111915.
Nguyen Cao TG, Kang JH, You JY, Kang HC, Rhee WJ, Ko YT, Shim MS. Protected and focused sonodynamic most cancers remedy utilizing biocompatible exosome-based nanosonosensitizers. ACS Appl Mater Interfaces. 2021;13(22):25575–88.
Cheng H, Fan JH, Zhao LP, Fan GL, Zheng RR, Qiu XZ, Yu XY, Li SY, Zhang XZ. Chimeric peptide engineered exosomes for dual-stage mild guided plasma membrane and nucleus focused photodynamic remedy. Biomaterials. 2019;211:14–24.
Cao H, Wang H, He X, Tan T, Hu H, Wang Z, Wang J, Li J, Zhang Z, Li Y. Bioengineered macrophages can responsively remodel into nanovesicles to focus on lung metastasis. Nano Lett. 2018;18(8):4762–70.
Ye Z, Zhang T, He W, Jin H, Liu C, Yang Z, Ren J. Methotrexate-loaded extracellular vesicles functionalized with therapeutic and focused peptides for the therapy of glioblastoma multiforme. ACS Appl Mater Interfaces. 2018;10(15):12341–50.
Li L, He D, Guo Q, Zhang Z, Ru D, Wang L, Gong Okay, Liu F, Duan Y, Li H. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian most cancers. J Nanobiotechnol. 2022;20(1):50.
Zhou Q, Ding W, Qian Z, Zhu Q, Solar C, Yu Q, Tai Z, Xu Okay. Immunotherapy technique concentrating on programmed cell demise ligand 1 and CD73 with macrophage-derived mimetic nanovesicles to deal with bladder most cancers. Mol Pharm. 2021;18(11):4015–28.
Forterre AV, Wang JH, Delcayre A, Kim Okay, Inexperienced C, Pegram MD, Jeffrey SS, Matin AC. Extracellular vesicle-mediated in vitro transcribed mRNA supply for therapy of HER2(+) breast most cancers xenografts in mice by prodrug CB1954 with out common toxicity. Mol Most cancers Ther. 2020;19(3):858–67.
Si Y, Guan J, Xu Y, Chen Okay, Kim S, Zhou L, Jaskula-Sztul R, Liu XM. Twin-targeted extracellular vesicles to facilitate mixed therapies for neuroendocrine most cancers therapy. Pharmaceutics. 2020;12(11):1079.
Fan M, Liu H, Yan H, Che R, Jin Y, Yang X, Zhou X, Yang H, Ge Okay, Liang XJ, et al. A CAR T-inspiring platform primarily based on antibody-engineered exosomes from antigen-feeding dendritic cells for exact stable tumor remedy. Biomaterials. 2022;282:121424.
Chen Okay, Si Y, Guan JS, Zhou Z, Kim S, Kim T, Shan L, Willey CD, Zhou L, Liu X. Focused extracellular vesicles delivered verrucarin A to deal with glioblastoma. Biomedicines. 2022;10(1):130.
Jang Y, Kim H, Yoon S, Lee H, Hwang J, Jung J, Chang JH, Choi J, Kim H. Exosome-based photoacoustic imaging guided photodynamic and immunotherapy for the therapy of pancreatic most cancers. J Management Launch. 2021;330:293–304.
Wang X, Ding H, Li Z, Peng Y, Tan H, Wang C, Huang G, Li W, Ma G, Wei W. Exploration and functionalization of M1-macrophage extracellular vesicles for efficient accumulation in glioblastoma and powerful synergistic therapeutic results. Sign Transduct Goal Ther. 2022;7(1):74.
Ding J, Lu G, Nie W, Huang LL, Zhang Y, Fan W, Wu G, Liu H, Xie HY. Self-activatable photo-extracellular vesicle for synergistic trimodal anticancer remedy. Adv Mater. 2021;33(7):e2005562.
Lara P, Huis In’t Veld RV, Jorquera-Cordero C, Chan AB, Ossendorp F, Cruz LJ. Zinc-phthalocyanine-loaded extracellular vesicles enhance efficacy and selectivity of photodynamic remedy in co-culture and preclinical fashions of colon most cancers. Pharmaceutics. 2021;13(10):1547.
Zhan Q, Yi Okay, Qi H, Li S, Li X, Wang Q, Wang Y, Liu C, Qiu M, Yuan X, et al. Engineering blood exosomes for tumor-targeting environment friendly gene/chemo mixture remedy. Theranostics. 2020;10(17):7889–905.
Luo C, Hu X, Peng R, Huang H, Liu Q, Tan W. Biomimetic carriers primarily based on large membrane vesicles for focused drug supply and photodynamic/photothermal synergistic remedy. ACS Appl Mater Interfaces. 2019;11(47):43811–9.
Wang J, Chen P, Dong Y, Xie H, Wang Y, Soto F, Ma P, Feng X, Du W, Liu BF. Designer exosomes enabling tumor focused environment friendly chemo/gene/photothermal remedy. Biomaterials. 2021;276:121056.
Zhang J, Ji C, Zhang H, Shi H, Mao F, Qian H, Xu W, Wang D, Pan J, Fang X, et al. Engineered neutrophil-derived exosome-like vesicles for focused most cancers remedy. Sci Adv. 2022;8(2):eabj8207.
Zhou W, Zhou Y, Chen X, Ning T, Chen H, Guo Q, Zhang Y, Liu P, Zhang Y, Li C, et al. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials. 2021;268:120546.
Belhadj Z, He B, Deng H, Track S, Zhang H, Wang X, Dai W, Zhang Q. A mixed “eat me/don’t eat me” technique primarily based on extracellular vesicles for anticancer nanomedicine. J Extracell Vesicles. 2020;9(1):1806444.
Ma C, He D, Tian P, Wang Y, He Y, Wu Q, Jia Z, Zhang X, Zhang P, Ying H, et al. miR-182 concentrating on reprograms tumor-associated macrophages and limits breast most cancers development. Proc Natl Acad Sci USA. 2022;119(6):e2114006119.
Guo Q, Li X, Zhou W, Chu Y, Chen Q, Zhang Y, Li C, Chen H, Liu P, Zhao Z, et al. Sequentially triggered bacterial outer membrane vesicles for macrophage metabolism modulation and tumor metastasis suppression. ACS Nano. 2021;15(8):13826–38.
Lee H, Park H, Noh GJ, Lee ES. pH-responsive hyaluronate-anchored extracellular vesicles to advertise tumor-targeted drug supply. Carbohydr Polym. 2018;202:323–33.
Fan Z, Xiao Okay, Lin J, Liao Y, Huang X. Functionalized DNA permits programming exosomes/vesicles for tumor imaging and remedy. Small. 2019;15(47):e1903761.
Zhan Q, Yi Okay, Li X, Cui X, Yang E, Chen N, Yuan X, Zhao J, Hou X, Kang C. Phosphatidylcholine-engineered exosomes for enhanced tumor cell uptake and intracellular antitumor drug supply. Macromol Biosci. 2021;21(8):e2100042.
Pandita D, Kumar S, Lather V. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and supply prospectives. Drug Discov Right this moment. 2015;20(1):95–104.
Can A, Celikkan FT, Cinar O. Umbilical wire mesenchymal stromal cell transplantations: a systemic evaluation of scientific trials. Cytotherapy. 2017;19(12):1351–82.
Lorenzini B, Peltzer J, Goulinet S, Rival B, Lataillade JJ, Uzan G, Banzet S, Mauduit P. Producing vesicle-free cell tradition additive for human cells extracellular vesicles manufacturing. J Management Launch. 2023;355:501–14.
Görgens A, Corso G, Hagey DW, Jawad Wiklander R, Gustafsson MO, Felldin U, Lee Y, Bostancioglu RB, Sork H, Liang X, et al. Identification of storage situations stabilizing extracellular vesicles preparations. J Extracell Vesicles. 2022;11(6):e12238.
Grangier A, Branchu J, Volatron J, Piffoux M, Gazeau F, Wilhelm C, Silva AKA. Technological advances in the direction of extracellular vesicles mass manufacturing. Adv Drug Deliv Rev. 2021;176:113843.
